Agilent Technologies (NYSE: A) and Koninklijke Philips (NYSE:PHG) are both large-cap computer and technology companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.
This is a breakdown of recent ratings and price targets for Agilent Technologies and Koninklijke Philips, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Agilent Technologies pays an annual dividend of $0.60 per share and has a dividend yield of 0.8%. Koninklijke Philips pays an annual dividend of $0.73 per share and has a dividend yield of 1.8%. Agilent Technologies pays out 28.6% of its earnings in the form of a dividend. Koninklijke Philips pays out 43.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Koninklijke Philips has increased its dividend for 2 consecutive years. Koninklijke Philips is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.
Volatility & Risk
Agilent Technologies has a beta of 1.28, indicating that its share price is 28% more volatile than the S&P 500. Comparatively, Koninklijke Philips has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500.
Institutional and Insider Ownership
7.2% of Koninklijke Philips shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
This table compares Agilent Technologies and Koninklijke Philips’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Earnings and Valuation
This table compares Agilent Technologies and Koninklijke Philips’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Agilent Technologies||$4.47 billion||5.15||$684.00 million||$2.10||33.92|
|Koninklijke Philips||$27.13 billion||1.40||$1.60 billion||$1.68||24.07|
Koninklijke Philips has higher revenue and earnings than Agilent Technologies. Koninklijke Philips is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks.
Agilent Technologies beats Koninklijke Philips on 10 of the 16 factors compared between the two stocks.
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
About Koninklijke Philips
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.